Bryan Goldman

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

Stephen R. Smalley, Jacqueline Benedetti, Daniel G. Haller et al. · Journal of Clinical Oncology · 2012 · 847 citations · Full text

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless et al. · Journal of Clinical Oncology · 2010 · 623 citations · Full text

Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer

Tanya B. Dorff, Bryan Goldman, Jacek Pinski et al. · Clinical Cancer Research · 2010 · 209 citations · Full text

Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916

Maha Hussain, Bryan Goldman, Cathy Tangen et al. · Journal of Clinical Oncology · 2009 · 208 citations · Full text

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

Guru Sonpavde, Bryan Goldman, V. O. Speights et al. · Cancer · 2009 · 195 citations · Full text